CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Seoul Pharma Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Seoul Pharma Co Ltd
603, Sihwa Industrial Complex 1 Ra
1248-8, Jeongwang-Dong
Phone: +82 437155800p:+82 437155800 CHEONGJU, 28158  South Korea Ticker: 018680018680
Business Summary
Seoul Pharma Co Ltd is a Korea-based company engaged in the manufacture and distribution of pharmaceuticals. The Company’s main products portfolio consists of drugs for cardio-vascular system, respiratory system and digestive system, antidiabetic drugs, anti-obesity drugs, antipyretic drugs, analgesic drugs, anti-inflammatory drugs, antibiotics, antibacterials, antifungal drugs, antiviral drugs, tonics, vitamins, minerals, creams, dugs for hypertension, antipyretics, drugs for skin disease, dugs for cough and phlegm redution, as well as ointments, among others. The Company distributes its products within domestic market and to overseas markets.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Wu SeongHwang 46 8/9/2018
Head of Production, Director Jae CheonGoh 62 3/15/2013 3/15/2013
Head of Overseas Business, Assistant Managing Director Geon HuiJang 53 3/31/2011 3/23/2011
Internal Auditor Jin SeongLee 55 3/24/2010 3/24/2010
Assistant Managing Director Gyu JeongYeon 50

Business Names
Business Name
018680
Seoul Pharma Co., Ltd.

General Information
Number of Employees: 176 (As of 12/31/2023)
Outstanding Shares: 11,659,319 (As of 12/31/2023)
Shareholders: 7,439
Stock Exchange: KDQ
Fax Number: +82 25971925


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024